Gainesville, FL, United States of America

Colin Sumners

This inventor holds 1 USPTO granted patent. Top assignee: University of Florida Research Foundation Inc.. Active years: 2003.


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Colin Sumners: Innovator in Neurological Treatment

Introduction

Colin Sumners is a notable inventor based in Gainesville, FL (US). He has made significant contributions to the field of neurological disorders through his innovative research and patent work. His dedication to improving treatment methods for various neurological conditions has positioned him as a key figure in this area of study.

Latest Patents

Colin Sumners holds a patent for "Materials and methods for treatment of neurological disorders involving overactivation of glutamatergic ionotropic receptors." This invention pertains to methods for treating neurological conditions that can be influenced by the modulation of glutamate receptor (GluR) activity. The treatment can be either prophylactic or aimed at alleviating symptoms of conditions such as ischemia, stroke, spinal cord injury, and traumatic brain injury. He has 1 patent to his name.

Career Highlights

Colin Sumners is affiliated with the University of Florida Research Foundation Inc., where he conducts his research and develops his innovative treatments. His work has garnered attention for its potential to significantly impact the lives of individuals suffering from neurological disorders.

Collaborations

Colin has collaborated with notable colleagues, including Donn Dennis and Alexander V Glushakov. These partnerships have enhanced his research efforts and contributed to the advancement of treatment methodologies in the field.

Conclusion

Colin Sumners is a dedicated inventor whose work in neurological treatment showcases his commitment to improving patient outcomes. His innovative approaches and collaborations continue to pave the way for advancements in the treatment of neurological disorders.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…